Background and purpose: The detection rate of atrial fibrillation has not been studied specifically in transient ischemic attack (TIA) patients although extrapolation from ischemic stroke may be inadequate. We conducted a systematic review and meta-analysis to determine the rate of newly diagnosed atrial fibrillation using different methods of ECG monitoring in TIA.
Introduction
Sensitive diagnosing of atrial fibrillation (AF) represents a major objective in stroke and transient ischemic attack (TIA) patients. 1 While growing evidence guides diagnostic work-up for detection of AF in stroke patients, the yield of various modalities of cardiac monitoring in TIA patients has not been studied specifically. 2, 3 Extrapolation of findings in stroke cohorts to TIA patients may be inadequate. Although TIAs are considered as part of the spectrum of ischemic stroke (IS), 4 the diagnosis of TIA is often based on medical history alone and is less definite. Moreover, the setting of cardiac diagnostic work-up for strokes and TIAs differs substantially. In many health care systems, TIAs are evaluated as outpatients [5] [6] [7] whereas strokes are admitted to monitored stroke units, 8, 9 Even if TIA patients are hospitalized, length of monitoring is shorter. 10 No systematic review assessing different techniques for AF detection in TIA patients is available. Thus, the optimal duration, method and timing of monitoring and the best candidates for prolonged monitoring in TIA are ill-defined.
We performed a systematic review and meta-analysis to determine the overall rate of newly detected AF after TIA. We also compared detection rates in selected (higher age, more extensive testing for arrhythmias before enrolment, or presumed cardioembolic/cryptogenic cause) and unselected TIA cohorts, and evaluated the impact of duration and type of monitoring.
Methods

Search strategy and data extraction
We performed a systematic review following PRISMA guidance ( Figure 1) 11 and a pre-specified study protocol. Relevant studies were identified using thesaurus subject headings (MEDLINE and EMBASE) and free text terms (supplementary Table 1 ). Google scholar, Cochrane library, clinical trial registries, and references lists from all included articles and abstracts were also assessed. Pre-defined eligibility criteria regarding study design, duration of monitoring, and AF definition were applied by two independent investigators (EK and SH). If necessary, authors were asked to provide information on eligibility criteria (e.g. study design, AF definition, exclusion of known AF cases, and duplicate publications). Corresponding authors of studies including both IS and TIA patients were contacted by email to provide data about characteristics and AF detection rates in TIA patients specifically. For studies which examined more than one method of ECG monitoring in the same cohort, detection rates were calculated for each method. Consequently, the number of pooled estimates exceeded the number of eligible studies.
Eligibility criteria
We 
Outcome measures
The main outcome measure was the overall rate of newly detected AF. The proportion of patients with AF in each subgroup was calculated by dividing the number of patients with newly detected AF by the total number of patients included in this group. Three subgroup analyses were performed. First, we determined the AF detection rate in unselected versus selected patients. Included studies used various selection criteria. Some included only ''cryptogenic'' TIAs or only supposedly embolic TIAs. Other selection criteria related to duration and methods of screening for cardiac arrhythmias before enrolment. Some studies only enrolled patients above a defined age. Second, we reported AF detection rates depending on duration of ECG monitoring which was categorized into intervals 24 h, between 24 h and 7 days, and >7 days. Finally, we estimated the AF detection rate depending on the non-invasive versus invasive monitoring.
Risk of bias assessment
We assessed the quality of the studies according to the Cochrane handbook. 12 We used a funnel plot and Egger's regression test in order to assess publication bias. 13 For the funnel plot, we plotted the AF detection rate (based on the double arcsine transformation) against the precision (1/standard error). A p value < 0.1 was considered significant for publication bias.
Statistical analysis
Four meta-analyses were performed to determine the overall AF detection rate in the total population and in predefined subgroups. We used the random-effects model for all analyses because a high degree of heterogeneity was expected among the included cohorts. By using random-effects models, we allowed that the true proportion of AF detection varied from one study to the next and we assumed that the studies in this analysis represented a random sample of detection proportions that could have been observed. That means by using random effects models, our goal was not to estimate one true detection proportion, but to estimate the mean of a distribution of detection proportions which also reflects variations in detection methods. Confidence intervals (CI) were calculated by the exact binomial method. Freeman-Tukey double arcsine transformation was used to stabilize the variance. Heterogeneity was assessed by the 2 -based Q statistics, a measure of variance on a relative scale, and by I 2 , a quantitative measure of inconsistency, which is neither sensitive to the metric of the analyzed quantity nor to the number of studies.Within a random effects model, heterogeneity between study subgroups was assessed using Q-statistics (expressed as ''Heterogeneity between groups'' in forest plots). Higher values of I 2 or values of p < 0.1 for the Q statistic-based 2 test suggest significant heterogeneity. Pooled proportion meta-analysis was performed using STATA (version 13.0). 14 
Results
Twenty-four articles, 16 full manuscripts and 8 abstracts, of 1205 identified citations fulfilled the eligibility criteria ( Figure 1 ). 3, Three studies (13%) were randomized controlled trials and 21 (87%) were prospective observational (online supplementary Table 2 ). After seven studies were excluded from the analysis because of missing data, 17 studies were included in the meta-analysis. Therein, 25 monitored study subgroups were reported because some studies investigated various diagnostic procedures in the same cohort ( Figure 2 ). Baseline characteristics were available for 14 studies (supplementary Table 2 ). Only one study was performed exclusively in TIA patients. 32 We excluded 147 patients because in 17 cases AF was detected at presentation, 27, 37 and for 130 patients the detection rate was not available. 15, 18, 25, 30, [34] [35] [36] Thus, a total of 1163 patients from 17 studies were eligible for analysis (supplementary Table 2 ). Since seven of these International Journal of Stroke, 12 (1) studies investigated more than one modality in the same study cohort, the number of included study subgroups exceeded the number of eligible studies. Thus, 1423 data sets from 25 cohorts were included in our meta-analysis. 3, 16, 17, [19] [20] [21] [22] [23] [24] [26] [27] [28] [29] [31] [32] [33] 37 Overall AF detection rate
The overall pooled proportion of TIA patients with newly detected AF using all diagnostic methods was 4% (95% CI: 2-7%) ( Figure 2 ). The study reporting the highest yield for AF detection (27%, 95% CI: 8-55%) used inpatient ECG monitoring. 29 No AF episodes were detected in seven other cohorts using different modalities. 19, 20, 22, 26, 29, 31, 33 Significant heterogeneity was observed among studies (I 2 ¼ 60.61%, p ¼ 0.00) ( Figure 2 ).
Subgroup analyses
We performed three different subgroup analyses in order to compare rates of AF detection (a) in selected (higher age, more extensive testing for arrhythmias before enrolment, or presumed cardioembolic/cryptogenic cause) and unselected cohorts (b) across different time intervals of monitoring (c) using invasive and noninvasive methods of monitoring.
The Q-test for heterogeneity of AF-detection rates between subgroups has been used as a method for comparing the summary AF-detection rates Proportion across subgroup. This Q-test for heterogeneity assesses the dispersion of the summary detection rates within subgroups about the overall combined AF-detection rate. The null hypothesis in this application has been: the variance of the distribution of the subgroup-specific summary AF-detection rates is zero, which means all subgroup-specific summary AF-detection rates are equal.
Selected versus unselected cohorts
Data regarding unselected and selected cohorts are presented in Tables 1 and 2 , respectively. Selection criteria differed substantially among groups ( Table 2 and supplementary Table 4 ). AF was more likely to be uncovered in selected (7%, 95% CI: 2-14%) compared to unselected patients (3%, 95% CI: 2-5%) with significant heterogeneity groups (p ¼ 0.041) ( Figure 3 ).
Duration of monitoring
Extending the duration of monitoring from 24 h to seven days conferred a 1% higher detection rate (4%; CI: 1-8% vs. 5%; 95% CI: 2-9%). Further extension of monitoring beyond seven days resulted in another 1% increase of AF detection (6%, 95% CI: 1-12%).
No significant heterogeneity was observed among groups (p ¼ 0.558) ( Figure 4 ).
Invasive versus Non-invasive monitoring
Invasive methods yielded a higher detection rate than non-invasive modalities (11%: 95% CI: 2-24% vs. 4%, 95% CI: 2-7%). Significant heterogeneity existed between groups (p ¼ 0.05). The heterogeneity among studies using invasive methods of monitoring was 0% ( Figure 5 ) but the small number of studies precluded an estimation of between-study variance with acceptable precision. Moreover, I 2 is truncated to zero when the Q statistic is smaller than its degrees of freedom. 38 Clearly, one limitation of this Q-test for heterogeneity is the very low power in the case of only three subgroups. Nevertheless, the p value for the test of heterogeneity between groups was 0.041 in the case of selected versus unselected studies and 0.05 in the case of grouping according to invasive or non-invasive monitoring indicate statistical evidence as well for possible differences of detection rates between selected patients and unselected patients as for possible differences between patients under invasive and under non-invasive monitoring. 
Assessment of publication bias
The funnel plot showed asymmetry, suggesting a possible publication bias. We acknowledge that the interpretation of funnel plot asymmetry may be inaccurate for assessment of publication bias in meta-analyses of proportions, particularly in case of low proportions. 39 In this setting, the choice for both vertical and horizontal axes is challenging, and it can lead to misinterpretation of funnel plot asymmetry. 40 To quantitatively assess the risk of bias, we performed an Egger regression test which was not significant (p ¼ 0.552), thus not allowing to reject the null hypothesis that there is no small study effect (online supplementary Figure 1 ). Overall, 82% of the included studies had possible selection bias. Potential funding bias was found in 29% of the studies. However, we anticipate a lower rate of reporting bias because AF detection rates were provided directly by the corresponding authors after personal communication in 70% of the included studies. Other risks of bias are presented in supplementary Table 5 .
Discussion
The major findings of this study are as follows: (1) the overall rate of newly detected AF in TIA patients is 4% when findings of different diagnostic tests are pooled.
(2) The AF detection rate was 7% in selected compared to 3% in unselected cohorts. (3) Invasive monitoring yielded substantially higher rates of AF detection than non-invasive methods. (4) The yield of monitoring for >7 days confers limited added value compared to 24 h. (5) Inpatient ECG monitoring resulted in a relatively high rate of AF detection. The overall new AF detection rate in TIA patients of 4% in our review is lower than rates reported in previous reviews of studies including both IS and TIA patients (i.e. 6.3-11.5%). [41] [42] [43] Previous meta-analyses revealed considerably higher heterogeneity assessed by I 2 (88.2-90.12%) compared to our study (I 2 ¼ 60.61%). 41, 43 A potential explanation for both lower AF detection rates and lower heterogeneity in our meta-analysis could be that we used stricter International Journal of Stroke, 12 (1) inclusion criteria for AF definition. We considered only studies with AF episodes lasting more than 30 s. In contrast, previous reviews including mixed IS and TIA cohorts attributed part of the observed heterogeneity and bias to less strict AF definitions. 41, 42 TIA patients only represent a relatively small proportion of patients enrolled in studies included in previous meta-analyses on both IS and TIA patients. Differences of baseline characteristics between IS and TIA patients are another potential cause of different detection rates. Moreover, the variability in TIA definitions across the included studies in our review may have led to an overestimation of the total number of TIA patients (supplementary Table 3 ). For example, Heterogeneity between groups: p = 0.041
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brain imaging was not required to rule out conditions mimicking TIAs in some studies, and TIA mimics are not at the same risk for subsequent stroke as patients with a confirmed diagnosis of TIA. 44 An alternative explanation for the lower prevalence of AF in TIA patients is that a proportion of newly detected AF in IS is attributed to the infarct (i.e. ''neurogenic AF''). As the majority of TIA patients have no or only small infarcts, 45 AF is unlikely to result from TIA. Among studies included into our review, only the CRYSTAL-AF trial included exclusively patients with infarcts on brain imaging, 46 whereas the remaining studies Heterogeneity between groups: p = 0.558
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Tarhuni 2014a recruited patients based on symptom-duration alone 4 (supplementary Table 4 ). The average incidence of AF was more than twice as high in selected compared to unselected TIA patients. The wide range of detection rates (0-27%) and the higher heterogeneity in selected cohorts may arise from selection criteria applied in this group. Patients were recruited into specific studies based on age, availability of cardiac tests before enrolment into studies, and presumed cardioembolic or ''cryptogenic'' etiology of TIA. Even in the ''cryptogenic TIA'' group, inclusion criteria varied from just negative ECG and 24-h Holter to pre-specified extensive diagnostic work-up before enrollment ( Supplementary  Table  4 ). Heterogeneity between groups: p = 0.050 Overall (I^2 = 60.61%, p = 0.00);
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Rizos 3, 20, 21, 24, [27] [28] [29] 37 whereas other studies recruited patients later than 30 days after TIA. 16, 17, 19, 22, 23, 31 In some studies, monitoring started immediately after admission in an inpatient setting, 3, 20, 21, 24, [27] [28] [29] 33, 36, 37 whereas patients received a monitor as outpatients in other studies [16] [17] [18] [19] 22, 23, 25, 26, 31, 32, 34, 35 Nevertheless, AF detection is more likely in selected patients with suspected embolism compared to unselected populations. 23, 31, 47 Older age, certain clinical and neuroimaging findings (e.g. cortical deficits and embolic lesion pattern, respectively), [48] [49] [50] and cardiovascular characteristics (e.g. higher risk stratification scores, atrial premature beats, enlarged left atrium) 51,52 may identify patients at higher risk of AF. Stratification according to risk may increase the yield of extensive diagnostic investigation.
Our finding that invasive monitoring yields much higher detection rates than non-invasive techniques (Figure 4 ) should be interpreted with caution. First, the number of TIA patients who received an insertable device was small (44 patients), and it is likely that TIA patients receiving invasive monitoring were selected (Supplemental Table 3 ). Two of the three studies assessing invasive monitoring reported an AF detection rate of 15%, 17, 31 whereas the third study failed to uncover any AF but only three young TIA patients were included. 19 Importantly, our comparison between invasive and non-invasive methods of monitoring is limited because the non-invasive group comprised a wide variety of monitoring periods (i.e. 24 h to 30 days). Because the importance of the duration of monitoring for AF detection has been unequivocally shown in stroke patients, we performed a separate meta-analysis addressing the impact of different monitoring periods. This analysis yielded only a limited additional yield of monitoring beyond seven days. It remains to be shown whether very extensive non-invasive recording as performed over 30 days in the EMBRACE trial in stroke and TIA patients results in a substantially higher rate of AF detection in unselected TIA patients. 23 In unselected and selected TIA cohorts, inpatient ECG monitoring yielded the highest rate of AF detection. 3, 29 Rapid cardiac assessment of TIA patients is more likely to occur in TIA inpatients with a recent episode. Recently revised guidelines recommend prolonged monitoring for AF after stroke or TIA if no cause is apparent. 7, 47 However, the optimal setting, method, duration, and timing of monitoring in TIA patients remain unknown as prospective studies specifically addressing TIA patients are lacking.
Our study has strengths and limitations. We report an overall AF detection rate of 4% but our results should be interpreted with caution because of significant heterogeneity among studies. We combined studies with different designs, methods, modalities, duration of monitoring and cohort characteristics. However, we performed three different subgroup analyses in order to evaluate the detection rates in selected and unselected cohorts as well as to explore the influence of the duration and modality (invasive versus non invasive) on AF detection rates after TIA. We performed a comprehensive search of the literature and followed a strict search protocol consistent with PRISMA guidance. On the other hand, we obtained data from only 17 of 24 eligible studies which may have led to a selection bias. However, the included studies reported on 89% of patients enrolled in all studies. Studies which examined more than one modality for detecting AF in the same patient population 3,20,29 were considered as different independent studies in our meta-analysis as in previous meta-analyses on the topic. 41, 43 This may have resulted in a spuriously small estimate of the variance of the effect size and in a high likelihood of a type I error. As sensitivity analyses including only one modality for each study at a time provided similar results (data not shown), we did not apply more complex methods of dealing with dependency such as multilevel meta-analysis and robust variance estimation which also have limitations. 53, 54 Furthermore, we were unable to assess the interval between the index event and the initiation of monitoring. However, our meta-analysis suggests that inpatient monitoring has a higher yield of AF detection in both selected and unselected patients. Funnel plot showed asymmetry suggesting a risk of bias. However, we tried to minimize publication bias by searching all potential studies independently of the language and type of publication in different databases. Finally, because most studies did not provide baseline characteristics for risk stratification including age, gender, and ABCD 2 score, further subgroup analyses were not possible.
Summary/conclusions
This systematic review and meta-analysis finds a lower detection rate of AF in TIA patients compared to previously published analyses of mixed cohorts of stroke and TIA patients in which predominantly stroke patients were included. Additional analyses suggest that selected patients or those undergoing invasive monitoring have higher rates of AF detection than unselected patients. As extrapolation from findings in stroke cohorts to TIA patients may be inadequate, prospective studies are needed to determine the most appropriate method and duration of prolonged cardiac monitoring in TIA patients specifically.
